How PDRN Works
PDRN breaks down into fragments that switch on a receptor, raise a second messenger and end in one measurable outcome. Here is the chain, step by step, with the evidence attached to each step — including the three steps where the evidence does not go as far as the marketing does.
12pathway steps
4pathway groups
3contested claims
1human in vivo measurement (n=1)
01 · Pathway
Twelve nodes, four groups, one parallel arm.
Signalling
steps 1–6The message: degradation → A2A → cAMP → PKA → PI3K/Akt → VEGF.
Tissue effects
steps 7, 8, 12Downstream of VEGF. Step 12 is a secondary effect.
Boundary conditions
steps 10–11Connected to the chain with a distinct, dashed relationship — not ordinary steps.
Continue
Take the chain somewhere else.
Topical vs InjectableThe same chain, for the two routes, dimension by dimension.Open the comparison →Evidence libraryThe papers behind each step, filterable by strength and year.Open the evidence →Product databaseWhat the topical products actually contain — and what their labels disclose.Open the database →